NCT02300545View on ClinicalTrials.gov

Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 8, 2015

Primary Completion Date

May 31, 2019

Study Completion Date

July 11, 2020

Conditions
Sarcoma, Soft TissueSoft Tissue Sarcoma
Interventions
DRUG

Pazopanib

Trial Locations (7)

32224

Mayo Clinic - Jacksonville, Jacksonville

52242

University of Iowa, Iowa City

53792

University of Wisconsin Clinical Science Center, Madison

55905

Mayo Clinic - Rochester, Rochester

60611

Northwestern University, Chicago

63110

Washington University School of Medicine, St Louis

85054

Mayo Clinic - Phoenix, Phoenix

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Washington University School of Medicine

OTHER